Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral nifedipine versus labetalol in treatment of postpartum hypertension
DRKS00014081Phase 2Active, not recruiting
- Sponsor
- prof ob& gyn prof mohamed mahmoud Assiut
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nifedipine and labetalol in hypertension (HTN) and pregnancy-induced hypertension (PIH) (2 arms), sponsored by prof ob& gyn prof mohamed mahmoud Assiut. Started Mar 2018; status: active, not recruiting.
02
Drugs
nifedipinelabetalol
03
Conditions
hypertension (HTN)pregnancy-induced hypertension (PIH)
Beyond the preview
Go deeper on DRKS00014081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00014081.